Featured in COVID-19Weekly FeaturedIf a patient develops a COVID-19 infection, should I stop my biologic?Discover this week's featured video and expert opinionCOVID-19 News & ResearchStudy Compares Baricitinib to Dexamethasone for COVID-19Baricitinib plus remdesivir shows similar efficacy but better safety profile than dexamethasone plus remdesivir in hospitalized adultsBy Physician’s Briefing Staff | June 21, 2022Low Dengue Incidence in 2020 Due to COVID-19-Related DisruptionStrongest evidence of association with reduced risk for measures related to school closures, reduced time spent in nonresidential areasBy Physician's Briefing Staff | March 16, 2022Baricitinib Reduces Mortality in Critically Ill Adults With COVID-19Reduction in death seen at 28, 60 days for patients receiving invasive mechanical ventilation, extracorporeal membrane oxygenationBy Physician’s Briefing Staff | February 18, 2022